The EMCTO webcast is supported by
an unrestricted educational grant by sanofi aventis
1. Official Welcome
(2009-05-01, 14:00:00 - 14:15:00)
ESMO
(R. Stahel)
CITY OF LUGANO
(A. Jelmini)
EMCTO SCIENTIFIC COMMITTEE
(R. Pirker)
2. Keynote lecture
(2009-05-01, 14:15:00 - 14:35:00)
MILESTONES IN THE MANAGEMENT OF LUNG CANCER
(R. Stahel)
3. WHO Keynote lecture
(2009-05-01, 14:35:00 - 14:50:00)
A THOUSAND SECONDS, A THOUSAND LIVES
(B. Zolty)
4. Lung cancer biology: Clinical implications
(2009-05-01, 14:55:00 - 16:15:00)
NEW FINDINGS IN THE MOLECULAR BIOLOGY OF LUNG CANCER: CLINICAL APPLICATION
(D. Gandara)
PROGNOSTIC FACTORS IN NON-SMALL CELL LUNG CANCER
(K. O\'Byrne)
PREDICTIVE FACTORS IN NSCLC
(E. Felip)
CLINICAL TRIALS BASED ON BIOMARKERS
(R. Rosell)
5. Diagnosis and staging
(2009-05-01, 16:45:00 - 18:15:00)
INVASIVE STAGING
(P. De Leyn)
INDIVIDUALISED STAGING: PRACTICAL IMPLICATIONS
(S. Spiro)
6. Case Discussions
(2009-05-01, 18:15:00 - 19:00:00)
7. Prevention and screening
(2009-05-02, 08:00:00 - 09:00:00)
THE PRIMARY PREVENTION OF LUNG CANCER
(G. Ostoros)
LUNG CANCER SCREENING
(R. van Klaveren)
8. NSCLC stage I and II. Treatment standards and new developments
(2009-05-02, 09:15:00 - 10:30:00)
SURGERY
(B. Passlick)
RADIOTHERAPY WITH CURATIVE INTENT FOR STAGE I AND II NON-SMALL CELL LUNG CANCER
(D. De Ruysscher)
SYSTEMIC THERAPY. NON SMALL CELL LUNG CANCER STAGE I AND II: TREATMENT STANDARDS AND NEW DEVELOPMENT
(G. Scagliotti)
FOLLOW-UP: WHY AND HOW
(V. Westeel)
9. NSCLC stage III
(2009-05-02, 10:50:00 - 12:20:00)
HETEROGENEITY OF STAGE III AND ITS IMPLICATION ON TREATMENT
(R. Huber)
SURGERY
(W. Weder)
NEW DEVELOPMENTS IN RADIOTHERAPY
(R. Dziadziuszko)
10. NSCLC Stage IV. Treatment standards and new developments
(2009-05-02, 14:00:00 - 15:30:00)
FIRST-LINE THERAPY
(P. Kosmidis)
SECOND LINE THERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER
(M. Cullen)
SURGERY IN SELECTED CASES
(W. Klepetko)
WILL STEREOTACTIC BODY RADIOTHERAPY PROLONG SURVIVAL IN PATIENTS WITH STAGE IV NSCLC?
(P. Baumann)
11. Neuroendocrine tumors, mesothelioma and thymoma
(2009-05-02, 15:45:00 - 17:15:00)
SMALL CELL LUNG CANCER
(J. Sculier)
OTHER NEUROENDOCRINE TUMORS
(E. Lim)
TUMORS OF THE THYMUS
(F. Venuta)
12. Special situations in lung cancer
(2009-05-02, 17:35:00 - 18:45:00)
13. Individualised therapy based on tumor features
(2009-05-03, 08:00:00 - 09:00:00)
CHALLENGES AND LIMITATIONS OF INDIVIDUALISED THERAPY
(M. Taron)
14. Elderly and co-morbid patients
(2009-05-03, 09:15:00 - 10:15:00)
SURGERY IN THE ELDERLY AND CO-MORBID DISEASE
(G. Rocco)
RADIOTHERAPY
(C. Faivre-Finn)
SYSTEMIC TREATMENT
(C. Gridelli)
15. European treatment guidelines
(2009-05-03, 10:20:00 - 11:00:00)
ESMO CLINICAL RECOMMENDATIONS - NSCLC
(G. D'Addario)
EUROPEAN TREATMENT GUIDELINES: SMALL CELL LUNG CANCER (SCLC)
(J. Soerensen)
EUROPEAN TREATMENT GUIDELINES: MESOTHELIOMA
(R. Stahel)
16. Future developments in multidisciplinary treatments: where are we going?
(2009-05-03, 11:20:00 - 12:50:00)
RADIOTHERAPY FOR STAGE III NON-SMALL CELL LUNG CANCER (NSCLC)
(D. De Ruysscher)
NSCLC STAGE IV
(L. Crino)
 

© 2009, EMCTO
To display the content of the website correctly you need Flash Player 8 for Windows or Flash Player 7 for MacOS. Download the newest version and install it, this requires only a few minutes.